Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma [Corrigendum]
Alekseeva AA, Moiseeva EV, Onishchenko NR, et al. Int J Nanomedicine. 2017;12:3735–3749. On page 3735, the first author’s name was incorrectly listed as Anna A Alekseeva. Her correct name is Anna S Alekseeva.Read the original article
Main Authors: | Alekseeva AS, Moiseeva EV, Onishchenko NR, Boldyrev IA, Singin AS, Budko AP, Shprakh ZS, Molotkovsky JG, Vodovozova EL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-07-01
|
Series: | International Journal of Nanomedicine |
Online Access: | https://www.dovepress.com/httpscorrigendum-wwwdovepresscomliposomal-formulation-of-a--peer-reviewed-article-IJN |
Similar Items
-
Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma
by: Alekseeva AA, et al.
Published: (2017-05-01) -
Phosphatidylinositol Stabilizes Fluid-Phase Liposomes Loaded with a Melphalan Lipophilic Prodrug
by: Daria Tretiakova, et al.
Published: (2021-04-01) -
Synthesis of Two Methotrexate Prodrugs for Optimizing Drug Loading into Liposomes
by: Valentina Di Francesco, et al.
Published: (2021-03-01) -
Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy
by: Xing J, et al.
Published: (2019-07-01) -
The Effect of Ligand Lipophilicity on the Nanoparticle Encapsulation of Pt(IV) Prodrugs
by: Johnstone, Timothy, et al.
Published: (2014)